✦ LIBER ✦

O-243 Clinical benefits in patients with advanced non-small-cell lung cancer treated with gefitinib (“Iressa”, ZD1839) in the compassionate use program

✍ Scribed by Janne, Pasi A.; Gurubhagavatula, Sarada; Lucca, Joan; Ostler, Patricia; Skarin, Arthur T.; Fidias, Panos; Lynch, Thomas J.; Johnson, Bruce E.

Book ID: 118571633
Publisher: Elsevier Science
Year: 2003
Tongue: English
Weight: 193 KB
Volume: 41
Category: Article
ISSN: 0169-5002
DOI: 10.1016/s0169-5002(03)91901-5

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Activity of ZD1839 (Gefitinib, Iressa™)

Activity of ZD1839 (Gefitinib, Iressa™) in Previously Treated Patients with Recurrent and Advanced non—small-Cell Lung Cancer

✍ Angelia D. Gibson; Mark Socinski; Chandra P. Belani; Vinay K. Jain 📂 Article 📅 2002 🏛 CIG Media Group, LP. 🌐 English ⚖ 79 KB

P-612 Gefitinib (Iressa, ZD1839) is acti

P-612 Gefitinib (Iressa, ZD1839) is active as first-line, compassionate use therapy in patients with advanced non-small cell lung cancer (NSCLC)

✍ Argiris, Athanassios; Mittal, Namrata; Masters, Gregory 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 194 KB

Outcomes of patients with advanced non-s

Outcomes of patients with advanced non-small cell lung cancer treated with gefitinib (ZD1839, ‘Iressa’) on an expanded access study

✍ Jänne, Pasi A.; Gurubhagavatula, Sarada; Yeap, Beow Y.; Lucca, Joan; Ostler, Pat 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 134 KB

O-113 Clinical evaluation of gefitinib (

O-113 Clinical evaluation of gefitinib (Iressa, ZD1839) in combination with rofecoxib in cisplatin pre-treated relapsed non-small cell lung cancer

✍ O'Byrne, K.J.; Clarke, L.; Dunlop, D.; Ranson, Malcolm; Danson, S.; Botwood, N. 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 182 KB

825 Statistical analysis of survival in

825 Statistical analysis of survival in patients with advanced non-small-cell lung cancer (NSCLC) treated with gefitinib (‘Iressa’, ZD1839) in an expanded access program (EAP): preliminary results

✍ M. Wolf; D. Farina-Sisofo; J. Grous; G. Kennealey; J. Ochs 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 166 KB

Effects of ZD1839 (Iressa, gefitinib) tr

Effects of ZD1839 (Iressa, gefitinib) treatment on symptoms and quality of life in patients with advanced non-small cell lung cancer

✍ Ronald B Natale 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 240 KB